Bjasensil
Natural health product licensed in Canada
- Other names
- LeStonel
- Licence holder
- Herbase Nutrition Ltd.
- NPN or DIN-HM
- 80034209
- Status
- Active licence
- Licence date
- 30 July 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Saussurea costus Source : Racine | 65 mg | Not calculated |
| Sodium Sulfate Source : Minérale | 20 mg | Not calculated |
| Areca Catechu Source : Graine(s) Extraction ratio : 2.2:1 Dry plant equivalent : 100 mg | 30 mg | Not calculated |
| Magnolia officinalis Source : Stem Bark processed with ginger Extraction ratio : 2:1 Dry plant equivalent : 40 mg | 20 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Traditional Chinese Medicine to clear internal heat and drain dampness for disorders such as abdomen pain and constipation due to damp-heat retention in the gallbladder and obstruction of qi flow of the fu-organs.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80034209
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.